AngioDynamics ANGO Other accrued liabilities
Other accrued liabilities at other companies
Other financials
Where this comes from
Reported directly by AngioDynamics in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesCurrent.
The official record: AngioDynamics’s 10-Q, filed April 2, 2026, on SEC EDGAR. View the filing →
Ask your AI about AngioDynamics's other accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AngioDynamics's other accrued liabilities?
- AngioDynamics (ANGO) reported other accrued liabilities of $4.66M in Q4 2025.
- How has AngioDynamics's other accrued liabilities changed year-over-year?
- AngioDynamics's other accrued liabilities decreased by 19.1% year-over-year, from $5.76M to $4.66M.
- What is the long-term trend for AngioDynamics's other accrued liabilities?
- Over 4 years (2021 to 2025), AngioDynamics's other accrued liabilities has grown at a 31.2% compound annual growth rate (CAGR), from $2.5M to $7.39M.
- What does other accrued liabilities mean?
- This captures miscellaneous short-term obligations that do not fit into standard categories like accounts payable or accrued compensation. It often includes items such as customer deposits, short-term tax provisions, or other minor contractual liabilities. It provides insight into the breadth of the company's short-term financial commitments.